Cargando…

Large-scale prevention trials could provide stronger evidence for decision-makers: Opportunities to design and report with a focus on the benefit–harm balance

Detalles Bibliográficos
Autores principales:	Aschmann, Hélène E, McNeil, John J, Puhan, Milo A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036154/ https://www.ncbi.nlm.nih.gov/pubmed/35152791 http://dx.doi.org/10.1177/17407745211068549

Ejemplares similares

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
por: Yebyo, Henock G., et al.
Publicado: (2019)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
por: Yebyo, Henock G., et al.
Publicado: (2020)

Fingolimod versus interferon beta 1-a: Benefit–harm assessment approach based on TRANSFORMS individual patient data
por: Spanu, Alessandra, et al.
Publicado: (2022)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
por: Yebyo, Henock G., et al.
Publicado: (2018)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
por: Aschmann, Hélène E, et al.
Publicado: (2019)

A framework for organizing and selecting quantitative approaches for benefit-harm assessment
por: Puhan, Milo A, et al.
Publicado: (2012)

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis
por: Stegeman, Inge, et al.
Publicado: (2015)

Quantitative benefit–harm assessment for setting research priorities: the example of roflumilast for patients with COPD
por: Puhan, Milo A., et al.
Publicado: (2015)

Sun Exposure in Children: Balancing the Benefits and Harms
por: Jindal, Ankur K., et al.
Publicado: (2020)

Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
por: Puhan, Milo A., et al.
Publicado: (2015)

Cybersecurity and Decision Makers
por: De Fréminville, Marie
Publicado: (2020)

STRONGER FOCUS ON NUTRITION WITHIN HEALTH SERVICES COULD SAVE 3.7 MILLION LIVES BY 2025
Publicado: (2019)

Individualised benefit–harm balance of aspirin as primary prevention measure – a good proof-of-concept, but could have been better…
por: Thorat, Mangesh A.
Publicado: (2016)

Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study
por: Menges, Dominik, et al.
Publicado: (2021)

Decision Making with Imperfect Decision Makers
por: Guy, Tatiana Valentine, et al.
Publicado: (2012)

Balancing the benefits and harms of radiotherapy post-radical prostatectomy
por: Lamb, Benjamin W., et al.
Publicado: (2018)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

Adherence and Association of Digital Proximity Tracing App Notifications With Earlier Time to Quarantine: Results From the Zurich SARS-CoV-2 Cohort Study
por: Ballouz, Tala, et al.
Publicado: (2021)

Software project estimation: the fundamentals for providing high quality information to decision makers
por: Abran, Alain
Publicado: (2015)

Single-photon decision maker
por: Naruse, Makoto, et al.
Publicado: (2015)

Entangled-photon decision maker
por: Chauvet, Nicolas, et al.
Publicado: (2019)

Profiling dynamic decision-makers
por: Grabiszewski, Konrad, et al.
Publicado: (2022)

ChatGPT and mental healthcare: balancing benefits with risks of harms
por: Blease, Charlotte, et al.
Publicado: (2023)

Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations—A population-based cohort study
por: Domenghino, Anja, et al.
Publicado: (2022)

<xml><?covid-19-pmc?></xml>Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
por: Ballouz, Tala, et al.
Publicado: (2023)

Reflections from Key Policy Decision-makers on Integrated Care and the Value of Decision-maker Involvement in Research
por: Evison, Karen, et al.
Publicado: (2018)

Putting research in place: an innovative approach to providing contextualized evidence synthesis for decision makers
por: Bornstein, Stephen, et al.
Publicado: (2017)

Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study
por: Ballouz, Tala, et al.
Publicado: (2022)

Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses
por: Mayo-Wilson, Evan, et al.
Publicado: (2023)

Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement
por: O'Donoghue, C, et al.
Publicado: (2013)

In silico study of medical decision-making for rare diseases: heterogeneity of decision-makers in a population improves overall benefit
por: Wang, Juan, et al.
Publicado: (2018)

Patent Statistics for Decision Makers 2013
Publicado: (2013)

The right temporoparietal junction enables delay of gratification by allowing decision makers to focus on future events
por: Soutschek, Alexander, et al.
Publicado: (2020)

Together stronger: Intracolonial genetic variability occurrence in Pocillopora corals suggests potential benefits
por: Oury, Nicolas, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy between family decision-makers and non-decision-makers among college teachers
por: Xu, Rong, et al.
Publicado: (2023)

Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
por: Lindley, Richard I
Publicado: (2021)

Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women
por: Cyr, P.R., et al.
Publicado: (2021)

Decision Makers Use Norms, Not Cost-Benefit Analysis, When Choosing to Conceal or Reveal Unfair Rewards
por: Heimann, Marco, et al.
Publicado: (2013)

Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers
por: Lopata, Erin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ktsbi492l5ngd3vrprck8u86m4